FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387076005: Pyrazinamide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461254015 Pyrazinamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481190010 Pyrazinamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491854015 Pyrazinoic acid amide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
55851000195110 pirazinamide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
836731000172112 pyrazinamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70931000195117 Pyrazinamid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyrazinamide (substance) Is a Antituberculosis agent true Inferred relationship Some
Pyrazinamide (substance) Is a classe d'allergènes false Inferred relationship Some
Pyrazinamide (substance) Is a allergène médicamenteux false Inferred relationship Some
Pyrazinamide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antimycobacterial true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Pyrazinamide measurement Component True Pyrazinamide (substance) Inferred relationship Some 1
Product containing pyrazinamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide adverse reaction (disorder) Causative agent (attribute) True Pyrazinamide (substance) Inferred relationship Some 1
Allergy to pyrazinamide Causative agent (attribute) False Pyrazinamide (substance) Inferred relationship Some
Pyrazinamide 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrazinamide (substance) Inferred relationship Some
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrazinamide (substance) Inferred relationship Some
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrazinamide (substance) Inferred relationship Some
Allergy to pyrazinamide Causative agent (attribute) True Pyrazinamide (substance) Inferred relationship Some 1
Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Pyrazinamide (substance) Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pyrazinamide (substance) Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Pyrazinamide (substance) Inferred relationship Some 3
Pyrazinamide 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Pyrazinamide (substance) Inferred relationship Some 2
Ethambutol and isoniazid and pyrazinamide and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Isoniazid and pyrazinamide and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing only pyrazinamide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide 400 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyrazinamide (substance) Inferred relationship Some 1
Pyrazinamide 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyrazinamide (substance) Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyrazinamide (substance) Inferred relationship Some 2
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pyrazinamide (substance) Inferred relationship Some 1
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pyrazinamide (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start